SWOG clinical trial number
S1316

Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction

Open
Phase
III
Accrual
100%
Abbreviated Title
Surgery vs Non-Surgical Management for MBO
Status Notes
Re-Activation - Effective 6/1/18
Activated
03/09/2015
Participants
ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS LISTED ON TITLE PAGE

Research committees

Cancer Survivorship
Gastrointestinal Cancer

Treatment

Surgery Non-surgical management

Other Study Materials

Eligibility Criteria Expand/Collapse

Must have malignant bowel obstruction (MBO); must have MBO due to an intra-abdominal primary cancer; must be able to tolerate a major surgical procedure based on clinical evaluation, status of their cancer, and any other underlying medical problems; a member of the surgical team must indicate equipoise for the benefit of the surgical treatment for MBO; pts must not have signs of bowel perforation or "acute" abdomen as evidenced by free air on radiologic imaging or peritonitis on a physical exam within 2 days prior to reg; must be registered within 3 days after surgical consult for MBO and prior to any treatment for MBO; Zubrod PS 0-2 within 7 days prior to reg; must plan to collect serum albumin after admission, but prior to treatment; must be able to complete study questionnaires in English; must be >/= 18 years old.

Publication Information Expand/Collapse

2020

Intellectual Equipoise and Challenges: Accruing Patients with Advanced Cancer to a Trial Randomizing to Surgical or Non-Surgical Management (SWOG S1316)

G Deutsch;J Deneve;M Al-Kasspooles;V Nfonsam;C Gunderson;A Alvarez Secord;P Rodgers;S Hendren;E Silberfein;ML Grant;J Sloan;V Sun;K Arnold;G Anderson;R Krouse American Journal of Hospice & Palliative Medicine Jan;37(1):12-18; May 23, 2019 [Epub ahead of print]

PMid: PMID31122027 | PMC number: PMC6868288

Sociocultural Factors of Cancer Clinical Trial Recruitment and Multidisciplinary Team Recruitment of Latin-American Patients in Mexico, Peru and Colombia

D Isla;R Krouse;A Mohar;A Leon;M Sanchez;O Guevara;M Lopez;LG Mora;N Macavilca;IC Carrillo International Conference on Advancing the Science of Cancer in Latinos (Feb 26-28, 2020, San Antonio, TX), poster

2015

Prospective comparative effectiveness trial for malignant bowel obstruction: SWOG S1316

RS Krouse American College of Surgeons Bulletin Dec;100(12):49-50

PMid: PMID26749971

Other Clinical Trials

SWOG Clinical Trial Number
S1922

Randomized Phase II Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma

Research Committee(s)
Gastrointestinal Cancer
Activated
12/16/2019
Accrual
2%
Open
Phase
II
SWOG Clinical Trial Number
S1815
SWOG Clinical Trial Number
S1613